Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder
Genes · 2023
DOI: 10.3390/genes14112037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Marco Paolini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatry and Clinical Psychobiology Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Ministero dell'Università e della Ricerca, Italian Ministry of Health.
Abstract (Originalsprache)
Despite the increasing availability of antidepressant drugs, a high rate of patients with major depression (MDD) does not respond to pharmacological treatments. Brain-derived neurotrophic factor (BDNF)-tyrosine receptor kinase B (TrkB) signaling is thought to influence antidepressant efficacy and hippocampal volumes, robust predictors of treatment resistance. We therefore hypothesized the possible role of BDNF and neurotrophic receptor tyrosine kinase 2 (NTRK2)-related polymorphisms in affecting both hippocampal volumes and treatment resistance in MDD. A total of 121 MDD inpatients underwent 3T structural MRI scanning and blood sampling to obtain genotype information. General linear models and binary logistic regressions were employed to test the effect of genetic variations related to BDNF and NTRK2 on bilateral hippocampal volumes and treatment resistance, respectively. Finally, the possible mediating role of hippocampal volumes on the relationship between genetic markers and treatment response was investigated. A significant association between one NTRK2 polymorphism with hippocampal volumes and antidepressant response was found, with significant indirect effects. Our results highlight a possible mechanistic explanation of antidepressant action, possibly contributing to the understanding of MDD pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Psychiatry and Clinical Psychobiology Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
- Mood Disorders Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
- Faculty of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.
- Faculty of Psychology, Vita-Salute San Raffaele University, 20132 Milan, Italy.
ORCID-Profile: Cristina Lorenzi, Sara Spadini, Raffaella Zanardi
Förderung
- Ministero della Salute
- Ministero dell'Università e della Ricerca
- Italian Ministry of Health
- Italian Ministry of University and Scientific Research
Zitieren
APA
Paolini, M., Fortaner-Uyà, L., Lorenzi, C., Spadini, S., Maccario, M., Zanardi, R., Colombo, C., Poletti, S., & Benedetti, F. (2023). Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder. Genes. https://doi.org/10.3390/genes14112037
Vancouver
Paolini M, Fortaner-Uyà L, Lorenzi C, Spadini S, Maccario M, Zanardi R, et al. Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder. Genes. 2023. doi:10.3390/genes14112037
BibTeX
@article{Paolini2023,
author = {Paolini, Marco and Fortaner-Uyà, Lidia and Lorenzi, Cristina and Spadini, Sara and Maccario, Melania and Zanardi, Raffaella and Colombo, Cristina and Poletti, Sara and Benedetti, Francesco},
title = {Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14112037}
}
EUVIMED